Stimuli-Responsive Nanocarriers for Targeted Drug Delivery: Design Strategies, Clinical Progress, and Translational Challenges

Lakshmikanta Lakshmikanta, Vaishalli Vaishalli, Mayank David Raiborde, G Kranthi Kishore, P. S. Vikhe, Mushini Srikanthakumari · Dr. Yashwant Research Labs Pvt. Ltd. · 2026

Stimuli-responsive nanocarriers are advanced systems designed to release drugs in response to specific biological or external signals, enhancing targeted drug delivery.

High AI ConfidenceStrong SourceConceptEarly Research

Plain English summary

This review discusses stimuli-responsive nanocarriers that release drugs in response to specific signals, improving targeted drug delivery. It examines design principles, material platforms, and clinical progress, highlighting challenges in translating these systems to clinical use. The review emphasizes the need for simpler, programmable designs and better patient stratification for effective treatment.

Why this matters

Stimuli-responsive nanocarriers could significantly improve the effectiveness of drug delivery by ensuring that medications are released precisely where needed, reducing side effects and enhancing patient outcomes. Understanding and overcoming the challenges in their clinical translation is crucial for advancing cancer treatment and other medical applications.

Key findings

  • Stimuli-responsive nanocarriers can respond to both endogenous and exogenous signals.
  • They aim to maximize drug concentration at the target site while minimizing side effects.
  • The review highlights various types of stimuli-responsive systems, including pH-sensitive and thermosensitive carriers.
  • Clinical translation is hindered by biological variability and complex manufacturing processes.
  • Future advancements depend on programmable designs and better patient selection.

What's new

The review critically evaluates the current state of stimuli-responsive nanocarriers, distinguishing between clinically approved and investigational systems, and emphasizes the need for simpler designs.

Limitations

The abstract notes that clinical translation is limited by factors such as biological heterogeneity, complex manufacturing, and regulatory uncertainty.

Commercial context

The clinical translation of stimuli-responsive systems remains limited and requires further development and validation.

Publication

Publisher
Dr. Yashwant Research Labs Pvt. Ltd.
Publication date
June 17, 2026
Research type
Paper

Tags

More on Stimuli-Responsive Materials

See all →
Stimuli-Responsive Materialspaper· May 30, 2026

Transformer-Based Deep Learning Framework for Predicting Stimuli-Responsive Release Profiles in Nano-Drug Delivery Systems

A Transformer-based deep learning framework predicts drug release profiles from stimuli-responsive nanocarriers with high accuracy.

Venkateswaran Govindarajulu, Lokesh K · Dr. Yashwant Research Labs Pvt. Ltd.Simulation
Stimuli-Responsive Materialspaper· May 25, 2026

Smart Stimuli-responsive Nanocarriers in Nanotechnology-based Cancer Diagnosis and Treatment

Smart stimuli-responsive nanocarriers enhance cancer treatment by enabling targeted drug delivery and reducing side effects.

Soham Joshi, Ganesh Muleva +3 · Bentham Science Publishers Ltd.Unknown
Stimuli-Responsive Materialspaper· May 5, 2026

Stimuli-Responsive Nanocarriers for Targeted Drug Delivery: A Review

Smart nanocarriers enhance targeted drug delivery by responding to specific stimuli, improving therapeutic efficacy while minimizing side effects.

Vishal H. Thorat, Shagufta J. Pathan +4 · Dr. Yashwant Research Labs Pvt. Ltd.Unknown
Stimuli-Responsive Materialsarticle· May 5, 2026

Next Generation of Drug Delivery: Stimuli Responsive Drug Delivery Overview

Smart drug delivery systems enhance therapeutic effectiveness by providing controlled and targeted drug release in response to specific stimuli.

Harshada T. Nanaware, Vikrant N. Patil +5 · Dr. Yashwant Research Labs Pvt. Ltd.Unknown
Stimuli-Responsive Materialsnews· Apr 16, 2026

Light-activated gel could impact wearables, soft robotics, and more

A light-activated, biocompatible soft gel is reported to dramatically change its conductivity, supporting ionotronics-style interfaces for wearables and soft robotics.

· MIT News — MaterialsUnknown
Stimuli-Responsive Materialspaper· Apr 13, 2026

Stimuli-Responsive Drug Delivery Platforms Design Strategies and Therapeutic Applications

This research explores advanced stimuli-responsive drug delivery systems that enhance targeted therapy and precision medicine.

Dr Ranadheer Donthi, Andrea Varghese +4 · Dr. Yashwant Research Labs Pvt. Ltd.Unknown
Method note: Summaries and ratings on this page are generated by AI from the abstract only. Read the original paper for full context. · Model: gpt-4o-mini-2024-07-18